Α‐sarcin and RNase T1 based immunoconjugates: the role of intracellular trafficking in cytotoxic efficiency. (26th December 2014)

• Record Type: Journal Article
• Authors: Tomé‐Amat, Jaime; Ruiz‐de‐la‐Herrán, Javier; Martínez‐del‐Pozo, Álvaro; Gavilanes, José G.; Lacadena, Javier
• Is Part Of: FEBS journal. Volume 282:Number 4(2015)
• Page Start: 673
• Page End: 684
• Publication Date: 2014-12-26
• Subjects: Biochemistry -- Periodicals; Molecular biology -- Periodicals; Pathology, Molecular -- Periodicals; 572
• DOI: 10.1111/febs.13169
• Languages: English
• ISSNs: 1742-464X

Abstract

<abstract abstract-type="main" id="febs13169-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Toxins have been thoroughly studied for their use as therapeutic agents in search of an improvement in toxic efficiency together with a minimization of their undesired side effects. Different studies have shown how toxins can follow different intracellular pathways which are connected with their cytotoxic action inside the cells. The work herein presented describes the different pathways followed by the ribotoxin α‐sarcin and the fungal RNase T1, as toxic domains of immunoconjugates with identical binding domain, the single chain variable fragment of a monoclonal antibody raised against the glycoprotein A33. According to the results obtained both immunoconjugates enter the cells via early endosomes and, while α‐sarcin can translocate directly into the cytosol to exert its deathly action, RNase T1 follows a pathway that involves lysosomes and the Golgi apparatus. These facts contribute to explaining the different cytotoxicity observed against their targeted cells, and reveal how the innate properties of the toxic domain, apart from its catalytic features, can be a key factor to be considered for immunotoxin optimization.</p> </abstract>